InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
0
T+90 hit rate
57%
T+90 mean return
-3.4%
Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Powell Andrew Kenneth William, Director. Director active across 2 companies, notably Landec CORP \ca\. In total, 10 disclosures have been logged. Split: 1 buy · 0 sell. Total volume traded: €10k. History available since 1 June 2021. The latest transaction was disclosed on 1 March 2024 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations10 total
4,660 sharesCommon StockSEC:0001415889-24-015368:0
8,500 shares@ US$1.23100.0% of flowCommon StockSEC:0001209191-24-004385:0
Ideal exit: 26 Nov 2024 (T+270)
4,507 sharesCommon StockSEC:0001209191-23-034399:0
4,000 shares0Common StockSEC:0001209191-23-004300:0
7,059 shares@ US$9.5028.3% of flowCommon StockSEC:0001628280-22-016491:0
709 shares0Common StockSEC:0001209191-22-034601:0
5,500 shares0Common StockSEC:0001209191-21-067863:0
5,500 shares0Common StockSEC:0001209191-21-067863
8,303 shares@ US$11.6435.9% of flowCommon StockSEC:0001593968-21-001521:0
8,303 shares@ US$11.6435.9% of flowCommon StockSEC:0001593968-21-001521
10 of 10 declarations
About Powell Andrew Kenneth William
Andrew Kenneth William Powell is a Director at LANDEC CORP \CA\ and Aclaris Therapeutics, Inc. In this role, he contributes to the governance of the companies and strategic decision-making. Powell brings his expertise to support the missions of these firms.
